PT67937B - Process for the preparation of thymosin alpha1 and or analogue - Google Patents

Process for the preparation of thymosin alpha1 and or analogue

Info

Publication number
PT67937B
PT67937B PT67937A PT6793778A PT67937B PT 67937 B PT67937 B PT 67937B PT 67937 A PT67937 A PT 67937A PT 6793778 A PT6793778 A PT 6793778A PT 67937 B PT67937 B PT 67937B
Authority
PT
Portugal
Prior art keywords
analogue
preparation
thymosin alpha1
alpha1
thymosin
Prior art date
Application number
PT67937A
Other languages
English (en)
Portuguese (pt)
Other versions
PT67937A (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/871,563 external-priority patent/US4116951A/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PT67937A publication Critical patent/PT67937A/pt
Publication of PT67937B publication Critical patent/PT67937B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PT67937A 1977-04-22 1978-04-21 Process for the preparation of thymosin alpha1 and or analogue PT67937B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78989877A 1977-04-22 1977-04-22
US05/871,563 US4116951A (en) 1977-04-22 1978-01-23 [Asn2 ]-thymosin α1 and analogs thereof

Publications (2)

Publication Number Publication Date
PT67937A PT67937A (en) 1978-05-01
PT67937B true PT67937B (en) 1980-04-07

Family

ID=27120967

Family Applications (1)

Application Number Title Priority Date Filing Date
PT67937A PT67937B (en) 1977-04-22 1978-04-21 Process for the preparation of thymosin alpha1 and or analogue

Country Status (18)

Country Link
JP (1) JPS53137914A (it)
AT (1) AT364470B (it)
CA (1) CA1113088A (it)
CH (3) CH641152A5 (it)
DE (1) DE2817082A1 (it)
DK (1) DK147918C (it)
ES (1) ES469016A1 (it)
FI (1) FI781241A (it)
FR (2) FR2401134A1 (it)
GB (1) GB1590668A (it)
GR (1) GR71886B (it)
HU (1) HU180783B (it)
IT (1) IT1113134B (it)
LU (1) LU79488A1 (it)
NL (1) NL7804364A (it)
NO (2) NO781404L (it)
PT (1) PT67937B (it)
SE (1) SE447262B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4116951A (en) * 1977-04-22 1978-09-26 Hoffmann-La Roche Inc. [Asn2 ]-thymosin α1 and analogs thereof
DE2919592A1 (de) * 1979-05-15 1981-01-15 Max Planck Gesellschaft Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
EP0033384B1 (de) * 1980-01-18 1984-02-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunstimulierender Wirkung, und Thymosin-alpha-1-Fragmente
US4339427A (en) * 1980-04-14 1982-07-13 Hoffmann-La Roche Inc. Radioimmunoassay of thymosinα
EP0056594B1 (de) * 1981-01-14 1984-09-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunregulierender Wirkung und Thymosin-alpha-1-Fragmente
CN1058500C (zh) * 1993-02-03 2000-11-15 施塞克龙药品公司 胸腺素α－1衍生物
US6262230B1 (en) * 1994-01-28 2001-07-17 Sciclone Pharmaceuticals Inc. Analogs of thymosin α1

Also Published As

Publication number Publication date
IT7822629A0 (it) 1978-04-21
NL7804364A (nl) 1978-10-24
SE447262B (sv) 1986-11-03
FR2405926A1 (fr) 1979-05-11
FR2401134A1 (fr) 1979-03-23
FR2405926B1 (it) 1983-09-09
NO821608L (no) 1978-10-24
ES469016A1 (es) 1980-01-01
GB1590668A (en) 1981-06-03
NO148924C (no) 1984-01-11
DK169478A (da) 1978-10-23
ATA286178A (de) 1981-03-15
CA1113088A (en) 1981-11-24
DE2817082A1 (de) 1978-11-02
JPS53137914A (en) 1978-12-01
CH641152A5 (en) 1984-02-15
IT1113134B (it) 1986-01-20
FI781241A (fi) 1978-10-23
PT67937A (en) 1978-05-01
GR71886B (it) 1983-08-04
FR2401134B1 (it) 1983-09-30
CH640218A5 (en) 1983-12-30
AT364470B (de) 1981-10-27
NO148924B (no) 1983-10-03
NO781404L (no) 1978-10-24
CH641153A5 (en) 1984-02-15
HU180783B (en) 1983-04-29
SE7804612L (sv) 1978-12-20
DK147918B (da) 1985-01-07
DK147918C (da) 1985-08-19
LU79488A1 (de) 1979-05-25

Similar Documents

Publication Publication Date Title
GB2009742B (en) Process for the preparation of maytansinoids and d-maytansinoids
ZA786482B (en) Olefin-resin-metal bonded structure and process for its preparation
PH16835A (en) Isoxazole steroids and process for the preparation thereof
ZA783511B (en) Sulfamoyl-aryl-ketones and process for the preparation thereof
ZA781385B (en) Polypeptides and process for the preparation thereof
GB2006212B (en) Process for the preparation of d(-)-a-phenylglycine
DE2960275D1 (en) Process for the preparation of acyloxysilanes and possibly acyloxysiloxanes
PT67937B (en) Process for the preparation of thymosin alpha1 and or analogue
IL55209A (en) Process for the preparation of trifluoromethylphenols and certain such new compounds
DE2860170D1 (en) Process for the preparation of polyisocyanates and their use
ZA786299B (en) Process for the preparation of 3-iodo-and bromorifamycin s
GB2014581B (en) Tetrapeptides and methods for the preparation thereof
YU39178A (en) Process for obtaining pyrroloquinoxalinone and pyrrolobenzodiazepinone
DE2861245D1 (en) Process for the preparation of blocked polyisocyanates and blocked polyisocyanates obtainable thereby
ZA784023B (en) Substituted 2-cyclopropyl-chromones and process for their preparation
GB1545125A (en) Process for the preparation of bacon analogue and the like
IL55139A0 (en) Substituted 2-cyclopropyl-chromones and process for their preparation
IL55460A0 (en) 2-guanidinomethyl-indolines and processes for their preparation
DE2861249D1 (en) Process for the preparation of 21-hydroxy-20-methyl pregnanes
ZA781103B (en) Novel aryl-hexafuranosides and processes for their preparation
PT67994A (en) Benzylpyrimidines and process for the preparation thereof
ZA786976B (en) Peptide derivatives and process for the preparation thereof
JPS5484552A (en) Prostanic acid and its analogue
IL54372A (en) Process for the preparation of d thiazolidine-azetidinone
IL54596A0 (en) Haloraylmalonamidooxacephalosporins and processes for the preparation thereof